BioSpace News Archive

Genetown

Arch Raises $1.4 Million with Convertible Note Issuance and Warrant RepriceFinancing with long-term shareholders provides flexibility during product roll-out

Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel wound care and biosurgical devices, announces that it has raised $1.4M from long-term shareholders.

June 5, 2020
·
4 min read
Policy

Coronavirus (COVID-19) Update: Daily Roundup - June 05, 2020

TheU.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

June 5, 2020
·
2 min read
Biotech Bay

Castro Valley Health, Inc. Notifying Patients of Data Security Incident

Castro Valley Health, Inc. has become aware of a data security incident that may have involved some personal information of former patients.

June 5, 2020
·
3 min read
Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on June 9, 2020

Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) is pleased to announce the Company will host a Corporate Update Conference Call and Webcast on June 10th, 2020 at 9 am MT/11 am ET.

June 5, 2020
·
4 min read
Policy

Emergent BioSolutions Statement on U.S. District Court Decision

Today, the U.S. District Court for the District of New Jersey entered a decision in the patent litigation regarding NARCAN® (naloxone HCl) Nasal Spray 4mg/spray product.

June 5, 2020
·
1 min read
Policy

Opiant Pharmaceuticals Statement on U.S. District Court Decision

Today, the U.S. District Court for the District of New Jersey entered a decision in the patent litigation regarding NARCAN® (naloxone HCl) Nasal Spray 4mg/spray product.

June 5, 2020
·
1 min read